References
- Bonadonna G et al: The CMF program for operable breast cancer with positive axillary nodes: Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer 1977; 39(6 suppl): 2904–15
- McGuire WL et al: Current status of estrogen and progesterone receptors in breast cancer. Cancer 1977: 39(6 suppl): 2934–47
- Adair FE et al: Clinical effects of surgical and x-ray castration in mammary cancer. JAMA 1945: 128: 161
- Rosen PR et al: Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer. Cancer 1977; 39: 2194–2200
- Patey DH, Nabarro JD: Early (“prophylactic”) oophorectomy and adrenalectomy in carcinoma of the breast: A ten-year follow-up. Br J Cancer 1970; 24: 16–21
- Tagnon HJ: Antiestrogens in treatment of breast cancer. Cancer 1977: 39(6 suppl): 2959–64
- Kennedy BJ, French L: Hypophysectomy in advanced breast cancer. Am J Surg 1965; 110: 411–15
- Newsome HH et al: Medical and surgical adrenalectomy in patients with advanced breast carcinoma. Cancer 1977; 39: 542–6
- Schabel FM Jr: Rationale for adjuvant chemotherapy. Cancer 1977; 39(6 suppl): 2875–82